Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.30% | 1,077.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.30% | 1,077.42% | |||
| Cost of Revenue | 2.28% | 12.75% | |||
| Gross Profit | -2.28% | 22.08% | |||
| SG&A Expenses | 2.30% | -21.51% | |||
| Depreciation & Amortization | 0.00% | -50.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.29% | -0.34% | |||
| Operating Income | -2.28% | 21.91% | |||
| Income Before Tax | -2.28% | 20.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.28% | 20.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.28% | 20.87% | |||
| EBIT | -2.28% | 21.91% | |||
| EBITDA | -2.28% | 21.85% | |||
| EPS Basic | 0.00% | 44.00% | |||
| Normalized Basic EPS | 0.00% | 40.00% | |||
| EPS Diluted | 0.00% | 44.00% | |||
| Normalized Diluted EPS | 0.00% | 40.00% | |||
| Average Basic Shares Outstanding | 0.00% | 38.71% | |||
| Average Diluted Shares Outstanding | 0.00% | 38.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||